• Adjunct Professor, Global Health
  • Professor, Obstetrics and Gynecology

Department of Obstetrics & Gynecology
University of Washington
325 9th Ave Box 359865
Seattle, WA 98104
United States

Phone Number: 
206-744-8563
Fax: 
Email: 
eckert@uw.edu
Select from the following:
Biography 

Dr. Eckert is a Professor of Obstetrics & Gynecology with an Infectious Disease Fellowship whose clinical practice focuses in general ob/gyn, with expertise in vaginal and vulvar infections. Her practice is centered in the Harborview Women's Clinic. Dr. Eckert's research interests focus on the intersection of immunizations with reproductive health and cervical cancer prevention. She works in clinical research trials as well as policy development for cervical cancer screening in low resource settings, the HPV vaccine, and for maternal immunization.

Dr. Eckert is a consultant to the WHO and is serving as the coordinator to update WHO recommendations cervical cancer (CX CA) screening. She is now a technical expert on cx ca screening with I-Tech in Botswana, and previously for Malawi and Namibia

Dr Eckert also works in the field of maternal immunization. She served as the obstetrics lead for the Global Alignment of Immunization Safety in Pregnancy. She is an investigator for Phase 3 clinical trials of RSV vaccine in pregnancy. She is a liaison to ACIP for American College of Ob/Gyn

She was on the GAVI Immunization Review Committee for 6 years, and has consulted with GAVI.

Education 
  • MD (University of San Diego)
  • BS (Carleton College)
Country Affiliations 
Health Topics 
  • Cervical Cancer
  • Health Policy
  • Health Policy and Advocacy
  • Infectious Diseases
  • Prevention
Expertise 

Sexual assault, STDs, vaccines, endometritis, general obstetrics, gynecology, vaginitis, and cross-cultural medicine

Publications 

Eckert LO, Jones CE, Kachikis A, Azucena B, Tavares Da Silva F, Absalon J, Rouse CE, Khalil A, Cutland CL, Kochar S, Munoz FM. Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. Vaccine. 2020 June 15;38(29):4542-4547. PMID: 32448618.

de Sanjosé S, Temin S, Garland S, Eckert LO, Arossi S. Primary prevention of cervical cancer: American Society of Clinical Oncology resource-stratified guideline summary. J Onc Practice 2017 May 25; https://doi.org/10.1200/IOP.2017.02949. [Epub ahead of print]

Harrison MS, Eckert LO, Cutland C, et al.; Brighton Collaboration Pathways to Preterm Birth Working Group. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016 Dec 1;34(49):6093-6101. Epub 2016 Aug 1. PMCID: PMC5139807.

Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, Jeronimo J, Lu ER, Luciani S, Quek SC, Sankaranarayanan R, Tsu V, Broutet N; Guideline Support Group. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016 Mar;132(3):252-8. Epub 2015 Dec 14. PMID: 26868062.

Munoz FM, Eckert LO, Katz MA, Lambach P, Ortiz JR, Bauwens J, Bonhoeffer J. Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine. 2015 Nov 25;33(47):6441-52. Epub 2015 Sept 19. PMID: 26387433.

Eckert LO. Clinical Practice. Acute Vulvovaginitis. New Eng J Med 2006; 355(12):1244-52. PMID: 16990387.